Pancreatic cancer remains one of the most lethal of malignancies and a major health burden. We performed whole-genome sequencing and copy number variation (CNV) analysis of 100 pancreatic ductal adenocarcinomas (PDACs). Chromosomal rearrangements leading to gene disruption were prevalent, affecting genes known to be important in pancreatic cancer (TP53, SMAD4, CDKN2A, ARID1A and ROBO2) and new candidate drivers of pancreatic carcinogenesis (KDM6A and PREX2). Patterns of structural variation (variation in chromosomal structure) classified PDACs into 4 subtypes with potential clinical utility: the subtypes were termed stable, locally rearranged, scattered and unstable. A significant proportion harboured focal amplifications, many of which con...
The diagnosis of pancreatic neuroendocrine tumours (PanNETs) is increasing owing to more sensitive d...
Background: Pancreatic ductal adenocarcinoma (PDAC) is characterized by a 5-year survival rate of 4%...
We performed integrated genomic, transcriptomic, and proteomic profiling of 150 pancreatic ductal ad...
Pancreatic cancer remains one of the most lethal of malignancies and a major health burden. We perfo...
Published online 25 February 2015Pancreatic cancer remains one of the most lethal of malignancies an...
Pancreatic cancer remains one of the most lethal of malignancies and a major health burden.We perfor...
Pancreatic cancer remains one of the most lethal of malignancies and a major health burden. We perfo...
Pancreatic cancer remains one of the most lethal of malignancies and a major health burden. We perfo...
Pancreatic cancer remains one of the most lethal of malignancies and a major health burden. We perfo...
Pancreatic cancer remains one of the most lethal of malignancies and a major health burden. We perfo...
Pancreatic cancer has become the third leading cause of cancer-related death, with little improvemen...
none15Background: Pancreatic ductal adenocarcinoma (PDAC) is characterized by a 5-year survival rate...
Background: Pancreatic ductal adenocarcinoma (PDAC) is characterized by a 5-year survival rate of 4%...
Pancreatic cancer is molecularly diverse, with few effective therapies. Increased mutation burden an...
The diagnosis of pancreatic neuroendocrine tumours (PanNETs) is increasing owing to more sensitive d...
The diagnosis of pancreatic neuroendocrine tumours (PanNETs) is increasing owing to more sensitive d...
Background: Pancreatic ductal adenocarcinoma (PDAC) is characterized by a 5-year survival rate of 4%...
We performed integrated genomic, transcriptomic, and proteomic profiling of 150 pancreatic ductal ad...
Pancreatic cancer remains one of the most lethal of malignancies and a major health burden. We perfo...
Published online 25 February 2015Pancreatic cancer remains one of the most lethal of malignancies an...
Pancreatic cancer remains one of the most lethal of malignancies and a major health burden.We perfor...
Pancreatic cancer remains one of the most lethal of malignancies and a major health burden. We perfo...
Pancreatic cancer remains one of the most lethal of malignancies and a major health burden. We perfo...
Pancreatic cancer remains one of the most lethal of malignancies and a major health burden. We perfo...
Pancreatic cancer remains one of the most lethal of malignancies and a major health burden. We perfo...
Pancreatic cancer has become the third leading cause of cancer-related death, with little improvemen...
none15Background: Pancreatic ductal adenocarcinoma (PDAC) is characterized by a 5-year survival rate...
Background: Pancreatic ductal adenocarcinoma (PDAC) is characterized by a 5-year survival rate of 4%...
Pancreatic cancer is molecularly diverse, with few effective therapies. Increased mutation burden an...
The diagnosis of pancreatic neuroendocrine tumours (PanNETs) is increasing owing to more sensitive d...
The diagnosis of pancreatic neuroendocrine tumours (PanNETs) is increasing owing to more sensitive d...
Background: Pancreatic ductal adenocarcinoma (PDAC) is characterized by a 5-year survival rate of 4%...
We performed integrated genomic, transcriptomic, and proteomic profiling of 150 pancreatic ductal ad...